Temovate and Macroglobulinemia of waldenstrom - from FDA reports


Summary

There is no Macroglobulinemia of waldenstrom reported by people who take Temovate yet. We study 2,148 people who have side effects while taking Temovate from FDA. Find out below who they are, when they have Macroglobulinemia of waldenstrom and more.

What to expect?

If you take Temovate and have Macroglobulinemia of waldenstrom, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Temovate and have Macroglobulinemia of waldenstrom

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Temovate

Temovate has active ingredients of clobetasol propionate. (latest outcomes from Temovate 466 users)

Macroglobulinemia Of Waldenstrom

Macroglobulinemia of waldenstrom (cancer affecting b cells, a type of white blood cell) (latest reports from 11 Macroglobulinemia of waldenstrom patients).

On Feb, 25, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Macroglobulinemia of waldenstrom when taking Temovate?

Browse all side effects of Temovate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Macroglobulinemia of waldenstrom

Macroglobulinemia of waldenstrom

Could your condition cause Macroglobulinemia of waldenstrom

Macroglobulinemia of waldenstrom

Related studies